Published in J Antimicrob Chemother on September 11, 2014
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques. Antimicrob Agents Chemother (2017) 0.75
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol (2008) 2.36
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 2.19
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. J Pharm Biomed Anal (2011) 2.10
Perspectives and challenges of interferon-free therapy for chronic hepatitis C. J Hepatol (2012) 1.50
Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers. Antimicrob Agents Chemother (2010) 1.06
Telaprevir-based treatment effects on hepatitis C virus in liver and blood. Hepatology (2014) 0.99
Uniformity of liver density and nonheme (storage) iron distribution. Arch Pathol Lab Med (1987) 0.96
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents. AIDS (2011) 0.94
Gene expression analysis in serial liver fine needle aspirates. J Viral Hepat (2014) 0.93